Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$85.44 -2.10 (-2.40%)
As of: Sep 30, 2026 · 3:59 PM EDT

Mirum Pharmaceuticals (MIRM) Total Non-Current Liabilities (2019 - 2026)

Updated

Mirum Pharmaceuticals' Total Non-Current Liabilities was $994.25 million in Q2 2026, up 115.4% from $461.61 million a year earlier and up 65.7% from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Mirum Pharmaceuticals came in at $523.11 million, up 18.2% from FY2024.

  • Total Non-Current Liabilities has now increased for three consecutive years, with a five-year compound annual growth rate of 90.0% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $442.61 million in FY2024 (+12.3%), $394.1 million in FY2023 (+458.9%), $70.52 million in FY2022 (-59.1%) and $172.44 million in FY2021 (+716.6%).
  • The Q2 2026 figure marks the highest quarterly Total Non-Current Liabilities in data going back to Q2 2019.
  • Compared with a year earlier, Total Non-Current Liabilities has increased for 14 straight quarters, with growth averaging 27.5% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q4 2021 (growth of 716.6%); the worst was Q4 2022 (a decline of 59.1%).
  • Per Business Quant data, MIRM's Total Non-Current Liabilities in the three quarters before Q2 2026 was $600.17 million (Q1 2026), $523.11 million (Q4 2025) and $477.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Mirum Pharmaceuticals 5.67 Bn 4.09 Bn 145.90 Mn 994.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 994.25 Mn
Mar 31, 2026 600.17 Mn
Dec 31, 2025 523.11 Mn
Sep 30, 2025 477.09 Mn
Jun 30, 2025 461.61 Mn
Mar 31, 2025 443.09 Mn
Dec 31, 2024 442.61 Mn
Sep 30, 2024 431.90 Mn
Jun 30, 2024 427.79 Mn
Mar 31, 2024 413.07 Mn
Dec 31, 2023 394.10 Mn
Sep 30, 2023 381.55 Mn
Jun 30, 2023 364.97 Mn
Mar 31, 2023 191.29 Mn
Dec 31, 2022 70.52 Mn
Sep 30, 2022 57.03 Mn
Jun 30, 2022 50.83 Mn
Mar 31, 2022 36.28 Mn
Dec 31, 2021 172.44 Mn
Sep 30, 2021 52.49 Mn
API Access

Mirum Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MIRM&period=max&api_key=YOUR_API_KEY